Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (925)	2/5/2002 11:52:38 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2243

This is the Eli Gilboa procedure from Duke. Vieweg is conducting the telomerase trial for Geron, and that's prostate too. This is a different trial.

To: Arthur Radley who wrote (925)	2/6/2002 12:02:16 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2243

The study was supported by grants from the National Institutes of Health, the CaP CURE Foundation, and the National Center for Research Resources. Other authors of this study include: Axel Heiser, Doris Coleman, Dr. Jens Dannull, Donna Yancey, Margaret A. Maurice, Costas D. Lallas, Dr. Philipp Dahm, Donna Niedzwiecki and Eli Gilboa, all of Duke University Medical Center.